IP Library Patent Application 11983967
Patent Application
App. No. 11/983,967

Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/983,967
Abstract

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptides. In particular, the invention relates to novel stem cell growth factor-like polypeptides, including novel proteins named SCGF3248Fk081_aa2, SCGF3248Fk081_aa1, SCGFFk081_aa3, and SCGF323401Fe131_aa1. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Claims (16)

1 . A method of treating a subject in need of enhanced activity or expression of a polypeptide of SEQ ID NO:3, 6, 13 or 15, comprising administering to said subject a composition comprising a biologically effective amount of an amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO:3, 6, 13 or 15.

2 . The method of claim 1 , wherein said method is for treating a gastrointestinal disorder.

3 . The method of claim 1 , wherein said method is for treating bone or cartilage disease.

4 . The method of claim 1 , wherein said method is for wound healing.

5 . The method of claim 5 , wherein said method is for treating burns.

6 . The method of claim 5 , wherein said method is for treating ulcers.

7 . The method of claim 1 , wherein said method is for treating arthritis.

8 . A method of stimulating cell proliferation comprising contacting said cell with an amount of a polypeptide effective to promote proliferation of said cell, wherein said polypeptide comprises a cell proliferative amino acid sequence with at least 90% sequence identity to the amino acid sequence of SEQ ID NO:3, 6, 13 or 15.

9 . The method of claim 8 , wherein said cell is a stem cell.

10 . The method of claim 9 , wherein said cell is an embryonic stem cell.

11 . The method of claim 9 , wherein said cell is a hematopoietic cell.

12 . The method of claim 8 , wherein said cell is a bone cell, a bone-forming cell or a cartilage cell.

13 . The method of claim 8 , wherein said cell is a gastrointestinal cell.

14 . The method of claim 8 , wherein said method comprises contacting said cell in vitro.

15 . The method of claim 8 , wherein said method comprises contacting said cell in vivo.

16 . A method of promoting differentiation of a stem cell or germ cell comprising contacting said cell with an amount of a polypeptide effective to promote differentiation of said cell, wherein said polypeptide comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:3, 6, 13 or 15, and that exhibits stem cell growth factor activity.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 022235 FRAME 0181. ASSIGNOR CONFIRMS THE ASSIGNMENT. Recorded Mar 20, 2009
From: NUVELO, INC.
To: ARCA BIOPHARMA, INC.
Reel/Frame 022427/0425 →
RE-RECORD TO CORRECT THE NAME OF THE ASSIGNEE, PREVIOUSLY RECORDED ON REEL 022235 FRAME 0181. Recorded Mar 20, 2009
From: NUVELO, INC.
To: ARCA BIOPHARMA, INC.
Reel/Frame 022427/0431 →
MERGER Recorded Feb 9, 2009
From: NUVELO, INC.
To: ARCA BIOPHARAM, INC.
Reel/Frame 022235/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2008
From: TANG, Y. TOM
To: NUVELO, INC.
Reel/Frame 021202/0834 →